Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is not a medical recommendation
Review all safety data sheets and terms prior to use
Results showed higher sleep efficiency and shorter sleep latency with DSIP compared to placebo
In SURPASS-2, Tirzepatide was compared directly with once-weekly Semaglutide and demonstrated greater HbA1c reduction and greater weight reduction across the studied dose arms
PMC 5178091
Key points for its efficacy include the following: Antioxidant Action: One of the syntheses from glutathione towards scavenging free radicals, consequently limiting the extent of oxidative damage, which comprises global cellular health
US$ 24.97
US$ 24.60
US$ 25.04
